Advertisement
Organisation › Details
Atlas Antibodies AB
Atlas Antibodies was founded in 2006 as a start-up from the Human Protein Atlas project and has over the last 15 years successfully launched more than 60,000 products for protein research. The company was founded by researchers at the Royal Institute of Technology (KTH) in Stockholm and the Rudbeck Laboratory, Uppsala University in Uppsala to handle the production, marketing and sales of research tools developed by the Swedish-based Human Protein Atlas program. Headquartered in Stockholm, Sweden, Atlas Antibodies provides high-quality reagents for biomedical research, including polyclonal and monoclonal antibodies and QPrESTs. Earlier this year, Atlas Antibodies acquired UK-based HistoCyte Laboratories – a leading supplier of cell line controls for pathology applications, and Swiss-based evitria – an expert provider of antibody expression services. *
Start | 2006-01-01 established (s-off) | |
Group | Atlas Antibodies (Group) | |
Predecessor | University of Uppsala (Uppsala University) | |
Industry | research antibody | |
Industry 2 | reagents (bio/biochemical) | |
Person | Klæbel, Nille (Atlas Antibodies 202109– CEO before Philips Nordics + GSK + Sanofi + Novo Nordisk) | |
Person 2 | Jørgensen, Torben (Biotage 200604–201910 CEO before Affibody CEO before Karo Bio before Dako) | |
Region | Bromma | |
Country | Sweden | |
Street | 13 Voltavägen | |
City | 16869 Bromma | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Atlas Antibodies AB. (8/20/21). "Press Release: Atlas Antibodies AB Appoints Nille Klæbel as New CEO". | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Atlas Antibodies (Group)
- [1] Evitria AG. (8/8/22). "Press Release: Genovis AB Enters Service Agreement with Evitria AG for Fast LC-MS Analysis of Recombinant Antibodies"....
- [2] Atlas Antibodies AB. (8/20/21). "Press Release: Atlas Antibodies AB Appoints Nille Klæbel as New CEO"....
- [3] Atlas Antibodies AB. (7/28/21). "Press Release: Atlas Antibodies AB Acquires Evitria, a World Leader in Recombinant Antibody Expression". Stockholm & Zürich....
- [4] SHS Gesellschaft für Beteiligungsmanagement mbH. (12/20/18). "Press Release: SHS Invests in Swiss Life Science Company Evitria AG". Tübingen & Schlieren....
- [5] Merck KGaA. (6/19/18). "Press Release: Merck Signs Exclusive Agreement with HistoCyte Laboratories to Distribute Pathology Technology". Darmstadt....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top